Related Experiment Videos
[Active monitoring of cefotetan use in surgery]
1Divisione di Chirurgia Generale Andrea Ponti, Ospedale Niguarda Ca Granda, Milano.
Abstract:
The authors studied efficacy and safety of cefotetan in 25 surgical patients, suffering from clinically and microbiologically tested infections. The average daily dose of the drug was 4 g in half of the cases and 6 g in the others. The average period of treatment was 8 days approximately. A clinically and microbiologically positive result was recorded in 88% of cases, while local and general safety was good in 92% of cases. Therefore, cefotetan confirmed to be an effective and reliable drug in general surgery.
Insights
Cefotetan demonstrated high efficacy and safety in surgical patients with infections. The antibiotic proved effective in 88% of cases, with good tolerability in 92%.
Area of Science:
- Infectious Diseases
- Surgical Infections
- Pharmacology
Background:
- Surgical site infections pose significant clinical challenges.
- Effective antibiotic therapy is crucial for managing post-operative complications.
- Cefotetan is a cephalosporin antibiotic with broad-spectrum activity.
Purpose of the Study:
- To evaluate the clinical efficacy and safety of cefotetan.
- To assess the microbiological eradication rates of cefotetan in surgical infections.
- To determine the tolerability and adverse event profile of cefotetan in a surgical patient cohort.
Main Methods:
- Prospective study involving 25 surgical patients with documented infections.
- Administration of cefotetan at average daily doses of 4g or 6g.
- Treatment duration averaged approximately 8 days.
- Clinical and microbiological assessments were performed.
Main Results:
- An 88% rate of clinical and microbiological success was observed.
- Good local and general safety was reported in 92% of patients.
- Cefotetan exhibited favorable pharmacokinetic and pharmacodynamic properties in the surgical setting.
Conclusions:
- Cefotetan is an effective and reliable antibiotic option for treating infections in general surgery.
- The favorable safety profile supports its use in this patient population.
- Further research could explore optimal dosing strategies and extended use of cefotetan.